Salahadin Abdi

Salahadin Abdi is a tenured Professor and Associate Professor at The University of Texas MD Anderson Cancer Center. His research focuses on pain medicine, specifically chronic and neuropathic pain, with an emphasis on chemotherapy-induced peripheral neuropathy (CIPN) and its pharmacological management. His recent work includes investigating Nrf2 activators for analgesic effects in CIPN, using gait analysis as a quantitative indicator of neuropathy severity, and examining the link between post-acute sequelae of SARS-CoV-2 infection and neuropathic pain. He has also contributed to multisociety guidelines on corticosteroid injections and vaccine administration, and diagnostic guidance for Complex Regional Pain Syndrome. His publications span venues such as *Regional Anesthesia & Pain Medicine*, *International Journal of Molecular Sciences*, and *Frontiers in Pain Research*.